CMA Detection

The cma practice test of CapitalBio Technology uses Affymetrix GeneChip System
3000Dx and CytoScan 750K chip, it can not only provide accurate detection of
chromosomal gene abnormalities, and provide an effective diagnostic basis for
clinical birth defects, but also provide corresponding value-added services of
prenatal data analysis and report interpretation, which is more convenient for
clinicians' daily diagnosis and practical application.

Features of CMA Detection
ThermoFisher Affymetrix GeneChip System 3000Dx (GCS 3000Dx) chip system
provides accurate and rapid birth defect diagnosis services. It is the most
reliable platform for clinical research and the only chip system approved by
the US FDA and China CFDA with EU IVD and CE marks, suitable for RNA and DNA-
based clinical detection.

Product Coverage of CMA Detection
Prenatal detection and diagnosis of chromosomal abnormalities

Sample types: Peripheral blood, villi, amniotic fluid, cord blood and abortus

It can detect various chromosomal fetal chromosomal abnormalities, including
copy number variation (CNV), uniparental diploidy (UPD), loss of heterozygosity
(LOH), mosaicism, etc., such as Fancomi anemia or VACTERL syndrome caused by
CNV; UPD caused Angelman syndrome, Prader Willi syndrome; and chromosomal
abnormalities such as Autism, Cri-du-chat syndrome, Wolf Hirschhorn syndrome,
Williams Beuren syndrome, etc.

Neonatal genetic disease diagnosis

Sample type: Peripheral Blood

Precise genetic diagnosis of children with birth defects such as mental
retardation, developmental delay, polymorphism, autism, ADHD, epilepsy,
neuromuscular disorders, and congenital heart disease



Specification of CMA Detection
CNV probe 550,000
SNP probe 200,436 
Resolution 100kb
LOH/UPD ＞5MB


For more information about transcriptome sequencing service and in vitro
diagnostic assay, please feel free to contact us!

Click to Enlarge